Banini, Bubu A.Cazanave, Sophie C.Yates, Katherine P.Asgharpour, AmonVincent, RobertMirshahi, FaridoddinLe, PeterContos, Melissa J.Tonascia, JamesChalasani, Naga P.Kowdley, Kris V.McCullough, Arthur J.Behling, Cynthia A.Schwimmer, Jeffrey B.Lavine, Joel E.Sanyal, Arun J.2022-01-102022-01-102020-11Banini, B. A., Cazanave, S. C., Yates, K. P., Asgharpour, A., Vincent, R., Mirshahi, F., Le, P., Contos, M. J., Tonascia, J., Chalasani, N. P., Kowdley, K. V., McCullough, A. J., Behling, C. A., Schwimmer, J. B., Lavine, J. E., & Sanyal, A. J. (2019). Haptoglobin 2 Allele is Associated With Histologic Response to Vitamin E in Subjects With Nonalcoholic Steatohepatitis. Journal of Clinical Gastroenterology, 53(10), 750–758. https://doi.org/10.1097/MCG.00000000000011420192-0790https://hdl.handle.net/1805/27328Background: Haptoglobin (Hp) genotype has been linked to oxidative stress and response to vitamin E (VitE) in patients with dyslipidemia. Its effect on histological response to VitE in nonalcoholic steatohepatitis (NASH) is unknown. Goals: Our objective was to determine if Hp genotype associates with response to VitE in patients with NASH. Study: A post hoc analysis of 228 patients receiving VitE or placebo in two clinical trials was performed. Regression analysis was used to assess the effect of VitE versus placebo, by Hp genotype (1–1, 2–1, or 2–2), on histologic features and laboratory markers of liver disease, comparing baseline to end of treatment values. An interaction term was included in the regression models to assess differential treatment effect across Hp genotype. Results: Hp 2–2 patients treated with VitE versus placebo showed significant histologic improvement (51% versus 20%, OR=4·2, p=0·006), resolution of steatohepatitis (44% versus 12%, OR=6.2, p=0·009), decrease in NAFLD Activity Score (NAS) (−2·2 versus −0·6, p=0·001), and decrease in liver enzymes alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase and γ-glutamyl transpeptidase. Hp 2–1 patients on VitE versus placebo showed improved resolution of steatohepatitis, NAS and liver enzymes. Hp 1–1 patients showed no significant improvement in histology or liver enzymes. VitE had no effect on fibrosis stage in any group. Regression analysis showed incremental benefit of having Hp 2–2 or 2–1 versus 1–1 for all liver enzymes. Conclusion: Hp 2 allele is associated with greater histological and biological improvement in NASH with VitE treatment compared to the Hp 1 allele.en-USPublisher PolicyNonalcoholic steatohepatitisnonalcoholic fatty liver diseasevitamin Ehaptoglobin genotypeoxidative stresshaptoglobin genotypeArticle